GlassScriptPhysician profile
Akbar Dawood
NPI 1841498771
$668.56
in general payments reported to CMS, 2019-2025
8 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $21.50 · 2021: $112 · 2022: $80.66 · 2023: $59.87 · 2024: $69.44 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $205.56 | 2019-2025 | Biohorizons Dental Implants |
| Zimvie INC. | $125.36 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $100.00 | 2019 | |
| Straumann USA LLC | $78.78 | 2019-2021 | |
| Nobel Biocare USA | $59.87 | 2023 | Nobelactive |
| Keystone Dental INC. | $56.70 | 2019 | |
| Salvin Dental Specialties, INC. | $22.55 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.74 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akbar Dawood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.